Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Pain in Cleft Palate Repair
NCT02915042Phase 4Withdrawn
- Sponsor
- Baylor College of Medicine
- Start
- Dec 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Baylor College of Medicine. Primary endpoints: Total 24 hour dose of opioids and Postoperative pain control at 24 hours. Planned start Dec 2017; status: withdrawn.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02915042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02915042.